Evidence map›Paper›PMID 37801066›Full record

ArticleThe Journal of general physiology2023

A high-throughput electrophysiology assay to study the response of PIEZO1 to mechanical stimulation.

Nicoletta Murciano, Maria Giustina Rotordam, Nadine Becker, Melanie J Ludlow, Gregory Parsonage, Alexis Darras, Lars Kaestner, David J Beech, Michael George, Niels Fertig and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of general physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Open biology · 2025
    Review
  7. Review
  8. Pharmacology of PIEZO1 channels.British journal of pharmacology · 2024
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nicoletta Murciano *Nanion Technologies GmbH , München, Germany.ORCID 0000-0002-8046-7297
Maria Giustina Rotordam *Nanion Technologies GmbH , München, Germany.ORCID 0009-0005-4580-6264
Nadine BeckerNanion Technologies GmbH , München, Germany.ORCID 0009-0009-0372-5991
Melanie J LudlowLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds , Leeds, UK.ORCID 0000-0002-0720-5581
Gregory ParsonageLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds , Leeds, UK.ORCID 0000-0002-3666-5288
Alexis DarrasExperimental Physics, Saarland University, Saarbrücken, Germany.ORCID 0000-0003-1258-8465
Lars KaestnerTheoretical Medicine and Biosciences, Saarland University, Homburg, Germany.ORCID 0000-0001-6796-9535
David J BeechLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds , Leeds, UK.ORCID 0000-0002-7683-9422
Michael GeorgeNanion Technologies GmbH , München, Germany.ORCID 0009-0009-9729-3391
Niels FertigNanion Technologies GmbH , München, Germany.ORCID 0000-0002-9731-2283
Markus RapediusNanion Technologies GmbH , München, Germany.ORCID 0000-0002-9917-9922
Andrea BrüggemannNanion Technologies GmbH , München, Germany.ORCID 0000-0002-7325-6715
Nanion (Germany) · DEUniversity of Leeds · GBSaarland University · DE

Funding

British Heart Foundation RG/17/11/33042Wellcome Trust 110044/Z/15/Z
6 · The paper itself

Abstract

PIEZO1 channels are mechanically activated cation channels that play a pivotal role in sensing mechanical forces in various cell types. Their dysfunction has been associated with numerous pathophysiological states, including generalized lymphatic dysplasia, varicose vein disease, and hereditary xerocytosis. Given their physiological relevance, investigating PIEZO1 is crucial for the pharmaceutical industry, which requires scalable techniques to allow for drug discovery. In this regard, several studies have used high-throughput automated patch clamp (APC) combined with Yoda1, a specific gating modifier of PIEZO1 channels, to explore the function and properties of PIEZO1 in heterologous expression systems, as well as in primary cells. However, a combination of solely mechanical stimulation (M-Stim) and high-throughput APC has not yet been available for the study of PIEZO1 channels. Here, we show that optimization of pipetting parameters of the SyncroPatch 384 coupled with multihole NPC-384 chips enables M-Stim of PIEZO1 channels in high-throughput electrophysiology. We used this approach to explore differences between the response of mouse and human PIEZO1 channels to mechanical and/or chemical stimuli. Our results suggest that applying solutions on top of the cells at elevated pipetting flows is crucial for activating PIEZO1 channels by M-Stim on the SyncroPatch 384. The possibility of comparing and combining mechanical and chemical stimulation in a high-throughput patch clamp assay facilitates investigations on PIEZO1 channels and thereby provides an important experimental tool for drug development.

Indexed as

Ion ChannelsMechanotransduction, CellularElectrophysiologyHigh-Throughput Screening AssaysHumansIon ChannelsPIEZO1 protein, human

Identifiers

PMID37801066
PMCPMC10558326
OpenAlexW4387392837

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.